The bronchoscope market has seen considerable growth due to a variety of factors.
•In recent times, the bronchoscope market has seen robust expansion. The market size, currently at $2.95 billion in 2024, is expected to rise to $3.23 billion in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 9.5%.
This upward trend in the historic phase can be credited to the escalating consciousness and acceptance, amplification in medical education and training, employment of clinical applications and endobronchial interventions, the preference for less intrusive procedures, and the influence of an aging population.
The bronchoscope market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the bronchoscope market size is projected to experience a swift growth, expanding to "$5.04 billion in 2029 with a compound annual growth rate (CAGR) of 11.8%.
The expected growth during the forecast period can be linked to an increase in respiratory diseases, a growing aging population, demand for minimally invasive procedures, advancements in robotics, and attention on early diagnosis. Significant trends in the forecast period encompass miniaturization and portability, emphasis on patient safety and comfort, use of augmented reality (AR) and navigation systems, telemedicine and remote guidance, and use of disposable bronchoscopes.
The increase in instances of diseases impacting the respiratory system, which include conditions such as asthma, chronic obstructive pulmonary disease, pneumonia, bronchitis, cystic fibrosis, pulmonary fibrosis, and lung cancer, is anticipated to boost the growth of the bronchoscope market. The tool is commonly used in the diagnosis and treatment of a wide range of such disorders, causing the market for bronchoscopes to expand in tandem with the rise of these conditions. For instance, a report issued in June 2024 by the Australia-based government organization, Australian Institute of Health and Welfare (AIHW), disclosed that in 2023, chronic obstructive pulmonary disease (COPD) was responsible for 3.6% of the total disease burden, approximating 50% of the burden from respiratory conditions. In addition, in 2022, it was reported that 87% of COPD patients had one or more associated health conditions, the most common of which were mental and behavioral disorders (49%), arthritis (45%), and issues of asthma or back problems (42% each). Therefore, the bronchoscope market is likely to further develop as instances of respiratory tract disorders increase.
The bronchoscope market covered in this report is segmented –
1) By Type: Rigid Bronchoscopes, Flexible Bronchoscopes
2) By Usability: Reusable Bronchoscopes, Disposable Bronchoscopes
3) By Application: Diagnosis, Treatments
4) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Rigid Bronchoscopes: Adult Rigid Bronchoscopes, Pediatric Rigid Bronchoscopes, Therapeutic Rigid Bronchoscopes
2) By Flexible Bronchoscopes: Adult Flexible Bronchoscopes, Pediatric Flexible Bronchoscopes, Video Flexible Bronchoscopes, Single-Use Flexible Bronchoscopes
Major firms in the bronchoscope market are innovating and creating novel products like slim outer diameter bronchoscopes to increase patient comfort, augment access to distal airways, and enhance diagnostic and therapeutic abilities in minimally invasive procedures. These slim bronchoscopes are designed to be narrower, making access to smaller airways easier and increasing patient comfort during the procedures. As an example, in May 2024, Olympus Corporation, a Japanese firm specializing in medical technology and optics, introduced bronchoscopes that are compatible with the EVIS X1 endoscopy system. The bronchoscopes, BF-H1100 and BF-1TH1100, offer high-definition imaging and a slim exterior diameter to improve access to remote airways. The BF-H1100 provides a 2.2mm functioning channel, resulting in an 11% boost in suction, while the BF-1TH1100 possesses a 3.0mm functioning channel, offering a 29% increase in suction. Both versions feature a revamped image sensor for HDTV resolution and include advanced imaging technologies like BAI-MAC, TXI, RDI, and NBI, thereby improving diagnostic precision in bronchoscopic procedures.
Major companies operating in the bronchoscope market include:
• Ambu A/S
• Boston Scientific Corporation
• Cogentix Medical Inc.
• Cook Medical LLC
• Fujifilm Holdings Corporation
• Hoya Corporation
• Karl Storz Endoscopy SE & Co. KG
• Olympus Corporation
• PENTAX Medical
• Richard Wolf GmbH
• Teleflex Incorporated
• EFER Endoscopy Srl
• Lymol Medical Corporation
• Schindler Endoskopie Technology GmbH
• Schölly Fiberoptic GmbH
• Uptake Medical B.V.
• Broncus Medical Inc.
• Novatech SA
• Shanghai AoHua Photoelectricity Endoscope Co. Ltd.
• Rochling Group
• Stryker Corporation
• NeoScope Inc.
• Bryan Corporation
• CONMED Corporation
• Laborie Medical Technologies Corp.
• Envision Endoscopy Inc.
• SonoScape Medical Corp.
• Verathon Inc.
• Medtronic plc
North America was the largest region in the bronchoscope market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bronchoscope market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa